Publicaciones en colaboración con investigadores/as de Università de Roma La Sapienza (21)

2024

  1. Recommendations on maximising the clinical value of tissue in the management of patients with intrahepatic cholangiocarcinoma

    JHEP Reports, Vol. 6, Núm. 6

2023

  1. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

    Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480

  2. Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis

    Cells, Vol. 12, Núm. 16

2022

  1. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

    Journal of Hepatology, Vol. 76, Núm. 5, pp. 1109-1121

  2. Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids

    Hepatology, Vol. 76, Núm. 6, pp. 1617-1633

  3. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions

    Gut, Vol. 71, Núm. 8, pp. 1669-1683

  4. Setup of multidisciplinary team discussions for patients with cholangiocarcinoma: current practice and recommendations from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

    ESMO Open, Vol. 7, Núm. 1

2021

  1. Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancer (British Journal of Cancer, (2020), 123, 7, (1047-1059), 10.1038/s41416-020-0987-3)

    British Journal of Cancer

  2. Extracellular Signal-Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma Cells

    Hepatology, Vol. 74, Núm. 4, pp. 2007-2020

  3. Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System

    Hepatology, Vol. 73, Núm. 6, pp. 2311-2325

  4. REPLY:

    Hepatology

  5. REPLY:

    Hepatology

  6. Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development

    Blood, Vol. 138, Núm. 17, pp. 1583-1589

2020

  1. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

    Nature Reviews Gastroenterology and Hepatology, Vol. 17, Núm. 9, pp. 557-588

  2. Current and novel therapeutic opportunities for systemic therapy in biliary cancer

    British Journal of Cancer, Vol. 123, Núm. 7, pp. 1047-1059

  3. Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging

    Digestive and Liver Disease, Vol. 52, Núm. 11, pp. 1282-1293

  4. Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part II: Treatment

    Digestive and Liver Disease, Vol. 52, Núm. 12, pp. 1430-1442

2019

  1. CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1865, Núm. 9, pp. 2246-2256

  2. Cholangiocarcinoma: State-of-the-art knowledge and challenges

    Liver International

2017

  1. Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages

    Journal of Hepatology, Vol. 66, Núm. 1, pp. 102-115